Fludarabine and cytarabine as continuous sequential infusion for elderly patients with acute myeloid leukemia.

Abstract

Patients with an intermediate karyotype and those receiving ASCT had a significantly better clinical outcome. Results in terms of CR achievement, CD34+ cell collection and ASCT feasibility. A longer follow up is needed in order to evaluate the actual benefit on long-term survival.